Association of ERG and TMPRSS2‐ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0045|75|11|1216-1226

ISSN： 0270-4137

Source： THE PROSTATE, Vol.75, Iss.11, 2015-08, pp. : 1216-1226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer

By  

THE PROSTATE, Vol. 75, Iss. 9, 2015-06 ,pp. : 897-906

John Wiley & Sons Inc

Access to resources Recommend Favorite

ERG protein expression as a biomarker of prostate cancer

By Falzarano Sara Moscovita   Magi-Galluzzi Cristina  

Biomarkers in Medicine, Vol. 7, Iss. 6, 2013-12 ,pp. : 851-865

Future Medicine

Access to resources Recommend Favorite

Assessment of long‐term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy

By  

CANCER, Vol. 121, Iss. 22, 2015-11 ,pp. : 4071-4079

John Wiley & Sons Inc

Access to resources Recommend Favorite

The predictive value of ERG protein expression for development of castration‐resistant prostate cancer in hormone‐naïve advanced prostate cancer treated with primary androgen deprivation therapy

By  

THE PROSTATE, Vol. 75, Iss. 14, 2015-10 ,pp. : 1499-1509

John Wiley & Sons Inc

Access to resources Recommend Favorite

ERG is specifically associated with ETS-2 and ETV-4, but not with ETS-1, in prostate cancer

By            

International Journal of Molecular Medicine, Vol. 30, Iss. 5, 2012-01 ,pp. : 1029-1033

Spandidos Publications

Access to resources Recommend Favorite